Wellling’s and Motinova’s New E-bike Motor Series Debut at EUROBIKE 2022
14.7.2022 05:14:00 EEST | Business Wire | Press release
Motinova’s and Welling’s latest E-bike motor series debut at EUROBIKE 2022.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220713005981/en/
New Motinova and Welling E-bike motor series offerings at Booth H8-I20, EUROBIKE 2022 (Indoors) (Photo: Business Wire)
By 2030, the global E-Bike market will reach 19 million units. As the green and low-carbon lifestyle trends, E-bikes have gradually become an alternative choice for urban commuters and field riders. Welling and Motinova offer three central motors for large chain wheels: Welling W6000, Welling 8500, and Motinova MT6000, featuring higher power density, higher efficiency, shorter response time, and lower wastage rate.
Welling W6000 for urban E-bikes: This high-performing central motor for large chain wheels is compact and low-noise designed (under 52dB), enabling a quiet riding experience. Its innovative torque sensor can adapt to a highly flexible riding curve for different biking scenarios. Its algorithm allows high-precision delay and inertia compensation for a smoother and more stable riding experience.
Welling W8500 for mountain E-bikes: Its unique flat wire winding structure with optimized design can enable efficiency to reach 80%, and increase battery range in mountain biking. Its ultra-high overload capacity can run continuously at 75% peak torque while keeping the shell temperature below 60°C for longer service life and more powerful output. Its highly integrated design enables it to have a weight of less than 3 kg in a very compact size.
Motinova MT6000: This high-performing central motor for large chain wheels is designed for urban commuters. The motor is only 3 kg and is very delicate. It could provide a maximum assistance rate of 270% in a strong and quiet momentum. Its pedaling rate can reach as high as 100rpm with five riding modes. Bikers can enjoy the fun of riding in all kinds of road conditions.
Motinova motors for small chain wheels, such as the VOLANS and PEGASI series; cycle computers; accessories; and other biking offerings are also on exhibition. In the outdoor exhibition area, Motinova and Welling also provide a fun test riding experience, “Ride Longer, Live Better.”
Motinova and Welling will further enhance their core capabilities in the field of intelligent transportation and the two-wheel transportation market.
Motinova’s and Welling’s parent, Midea Industrial Technology, has built 27 R&D centers in China, Austria, India, and Japan, with an accumulation of more than 5,500 authorized patents.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220713005981/en/
Contact information
Zhang Haichun
zhanghc69@midea.com
+86-18600038145
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Even Realities Brings Classic Tortoiseshell Design to Smart Glasses with New Even G2 Brown 226.10.2026 16:00:00 EET | Press release
Even Realities, the company behind camera-free, display-first smart glasses, today introduced Brown 2, a new tortoiseshell-inspired colorway for Even G2, alongside two accessories: Even G2 Clip (Polarized) and the Even G2 Chain. Designed to bring the warmth and character of traditional tortoiseshell eyewear to smart glasses, Brown 2 features a newly developed material that carries its layered pattern throughout the frame rather than applying it as a surface finish. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261026502782/en/ Even G2 Chain. Photo Credit: Even Realities Each frame is individually shaped, pressed, tumbled, and polished for 20 hours, creating subtle variations that make every pair unique. Brown 2 is also the lightest Even G2 design to date, while retaining the camera-free, display-first technology that brings live translation, notifications, and a teleprompter directly into the wearer's field of view. "For sm
Incyte Highlights New Data Advancing its Gastrointestinal Cancer Portfolio at ESMO 202626.10.2026 15:45:00 EET | Press release
Incyte (Nasdaq:INCY) announced new results from its advancing oncology portfolio, including updated results for its KRAS G12D inhibitor (INCB161734) in pancreatic ductal adenocarcinoma (PDAC) and advanced or metastatic colorectal cancer (CRC), and its TGFβR2×PD-1 bispecific antibody (INCA338901) in microsatellite stable CRC (MSS CRC). The data were featured in three rapid oral sessions (Abstract #3137RO, Abstract #1007RO and Abstract #1954RO, respectively) at the European Society of Medical Oncology (ESMO) Congress 2026. “At Incyte we are focused on improving outcomes for people living with cancer. The data presented for INCB161734 and INCA33890 show the potential of both programs to improve the standard-of-care in hard-to-treat diseases,” said Pablo J. Cagnoni, M.D., President, Incyte and Global Head of Research and Development. “Across pancreatic and colorectal cancers, we continue to see encouraging evidence of clinical activity and manageable safety profiles, supporting the promise
Bending Spoons Completes the Acquisition of Miro26.10.2026 15:00:00 EET | Press release
Bending Spoons S.p.A. (NASDAQ: BSP) has completed the previously announced acquisition of Miro, the visual collaboration platform used by more than 250,000 organizations to brainstorm, plan, and build together. “Miro has built a strong business around a product that makes complex collaborative work feel simple,” said Luca Ferrari, Bending Spoons CEO and co-founder. “Miro’s versatility has made it useful across a broad range of industries and workflows, while creating a robust foundation for further expansion. We believe there’s significant potential to build on these strengths. We look forward to drawing on Bending Spoons’ technologies and expertise to make Miro even more useful to customers and support its continued growth.” “Teams depend on Miro for innovating, alignment, coordination, and decisioning, and that need is only growing,“ said Andrey Khusid, CEO and co-founder of Miro. “In Bending Spoons, Miro has an owner who invests for the long term and cares deeply about product quali
Dubai Culture Opens Registration for ISEA2026 Dubai26.10.2026 14:09:00 EET | Press release
Dubai Culture and Arts Authority (Dubai Culture) has opened registration for the 31st International Symposium on Electronic/Emerging Art (ISEA2026 Dubai), taking place from 6 to 15 November 2026 under the theme ‘ELYAH: Constellating Place, Data and Identity’. The symposium will be the largest edition to date, bringing together artists, researchers, and innovators from around the world to explore the intersection of art, science, and technology and exchange perspectives on the future of contemporary creative practice. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261026652826/en/ Dubai Culture Opens Registration for ISEA2026 Dubai (Graphic: AETOSWire) The event supports Dubai Culture’s efforts to advance the digital arts ecosystem, deliver on its Digital Arts Roadmap objectives, and empower local talent. It also reinforces Dubai’s position as a global cultural reference, a leader in innovation, a driver of the creative econo
Agendia Unveils Clinical Validation of AI-Driven Digital Pathology Approach26.10.2026 14:00:00 EET | Press release
Agendia, Inc., a leader in precision oncology for breast cancer, recently presented research introducing its investigational artificial intelligence (AI)-driven digital pathology approach for the MammaPrint®70-gene recurrence signature at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid. The podium presentation, delivered by co-founder and Chief Research Officer, Laura van ’t Veer, Ph.D., detailed the development and clinical validation of a deep learning pipeline that can infer MammaPrint (MP) risk categories directly from hematoxylin and eosin (H&E)-stained, whole-slide images (WSIs). The company also presented two additional posters highlighting data from the prospective, real-world FLEX Study (NCT03053193). “AI has been part of Agendia’s scientific foundation from the beginning and this study represents its continued evolution,” said Dr. Laura van ‘t Veer. "For the first time, we are presenting our work exploring whether the biological information represente
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom